Fall in the number of cancer diagnoses during the Covid-19 pandemic: impaired staging and prognosis
DOI:
https://doi.org/10.33448/rsd-v10i11.19762Keywords:
Covid-19; Cancer; Epidemiology; Biopsy; Diagnosis.Abstract
Introduction: The current Covid-19 pandemic is taking health hostage. The reduction in the number of cancer diagnoses during this context, already evidenced in many countries, calls attention to a possible new epidemic: that of cases of advanced tumors, in which the prognosis is certainly worse, in a health system such as the System Health Service (SUS), in which, under normal conditions, it is already difficult to offer treatments within adequate terms. Objective: to show the impact that Covid-19 caused on cancer patients, by mapping procedures for tracking, diagnosis and treatment of patients compared to the period of 2019, under a non-pandemic scenario. Methodology: this is a descriptive and quantitative epidemiological study. The search for the incidence of cancers in Brazil was carried out during the years 2019, 2020 and 2021, registered in the Notifiable Diseases Information System (SINAN) - DATASUS. Results and discussion: the reasons for this phenomenon are varied, including recommendations from the doctors themselves to postpone appointments, surgeries and routine exams, as well as reducing the capacity of hospitals with several sick health professionals, but mainly fear of patients leaving home for consultations and exams, coupled with the fear of becoming contaminated with the coronavirus in hospitals or clinics or even on public transport. Conclusion: The reduction in the number of biopsies for the diagnosis of cancer, as well as in other diagnostic criteria, has a very large impact on mortality corroborated by cancer.
References
Amorim, G. L. S., Assad, D. X., Ferrari, B. L. & Rosa, D. D. (2020). Breast oncology and the COVID-19 pandemic: Recommendations from the Brazilian Society of Clinical Oncology (SBOC). Brazilian Journal of Oncology, 16 (1), 1-8.
Bakouny, Z., Paciotti, M. & Schmidt, A. L. (2021). Cancer screening tests and cancer diagnoses during the Covid-19 pandemic. JAMA Oncololy, 7 (3), 458-460.
Carvalho, J. B., & Paes, N. A. (2019). Taxas de mortalidade por câncer corrigidas para os idosos dos estados do Nordeste brasileiro. Ciênc. saúde coletiva, 24(10), 3857-3866.
Dinmohamed, A. G., Visser, O., Verhoeven, R. H. & Siesling, S. (2020). Fewer cancer diagnoses during the COVID-19 epidemic in Netherlands. The Lancet Oncology, 21 (6), 750-751.
Hanna, T. P., Evans, G. A. & Booth, C. M. (2020). Câncer, COVID-19 e o princípio da precaução: priorizando o tratamento durante uma pandemia global. Nat Rev Clin., 17 (1), 268-270.
Liang, W., Guan, W. & Chen, R. (2020). Pacientes com câncer na infecção por SARS-CoV-2: uma análise nacional na China. Lancet Oncology, 21 (3): 335-337
Marron, J. M., Joffe, S., Jagsi, R., Spence, R. A. & Hlubocky, F. J. (2020). Ética e escassez de recursos: recomendações da ASCO para a comunidade oncológica durante a pandemia COVID19. J Clin Oncol., 38 (19), 1—5.
Mello, FA, Galle, LC, Prado, RL (2017). Prevenção do Câncer de Colo Uterino na Concepção da População Feminina de Uma Cidade do Interior do Estado de São Paulo. Colloquium Vitae, 9 (2): 45-52.
Oliveira, M. M., Malta, D. C., Guauche, H., Moura, L., & Silva, G. A. (2015). Estimativa de pessoas com diagnóstico de câncer no Brasil: dados da Pesquisa Nacional de Saúde, 2013. Rev. Bras. Epidemiol, 18 (2), 146-157.
Onder, G., Rezza, G. & Brusaferro, S. (2020). Taxa de letalidade e características de pacientes morrendo em relação ao COVID-19 na Itália. JAMA.
Santos, M. O. (2018). Estimativa 2018: Incidência de Câncer no Brasil. Rev Bras Cancerol, 64(1), 119-120.
Schrag, D., Hershman, D. L. & Basch, E. (2020). Prática de oncologia durante a pandemia de COVID-19. JAMA.
Silva, F. S., Silva, G. S., Costa, A. C. M., Carvalho Filha, F. S. S., Medeiros Júnior, F. C., & Câmara, J. T. (2019). Cuidados de enfermagem a pacientes oncológicos: revisão integrativa. Research., Society and Development, 8 (6), 1-9.
Silvestris, N., Moschetta, A., Paradiso, A., & Delvino, A. (2020). Pandemia de COVID-19 e a crise dos sistemas de saúde: a experiência da Apulia Cancer Network e do Comprehensive Cancer Center Istituto Tumori “Giovanni Paolo II” de Bari. Jornal Internacional de Pesquisa Ambiental e Saúde Pública, 17 (8), 2763-2770.
van de Haar, J., Hoes, L. R. & Coles, C. E. (2020). Cuidando de pacientes com câncer na era COVID-19. Nat Med., 26 (5), 665-671.
Zhao, N., Shi, J., Zeng, L., & Yang, S. (2020). Características clínicas e estratégias de enfrentamento de neoplasias com infecção por coronavírus em 2019. Jornal Chinês de Câncer de Pulmão, 23 (4), 261-268.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Bárbara Queiroz de Figueiredo; Ana Caroline Barcelos Souza; Brunna Gonçalves Machado; Cláudia Assis Siqueira; Gabriel Augusto Batista Alves; João Pedro de Miranda Carvalho; Letícia Santos de Barros Moreira; Luis Ferreira Neto; Marianna Dutra Milagre; Matheus Lemes Baliano
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
